title: [Fulminant hepatitis B as a result of reactivation in hematologic patient after chemotherapy combined with rituximab].
authors.affiliation: Purificación Cantudo-Muñoz. Area de Microbiología. UGC Laboratorio de Análisis Clínicos. Hospital San Agustín. Avenida San Cristóbal s/n. Linares (Jaén), Spain. purificacion.cantudo.sspa@juntadeandalucia.es.
authors.forename: Purificación
authors.initials: P
authors.lastname: Cantudo-Muñoz
authors.forename: María Magdalena
authors.initials: MM
authors.lastname: Anguita-Arance
authors.forename: Cristina
authors.initials: C
authors.lastname: Muñoz-Peña
authors.forename: Carmen
authors.initials: C
authors.lastname: Amores-Antequera
mesh_terms: D000368:Aged; D058846:Antibodies, Monoclonal, Murine-Derived / Q000009:adverse effects* / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D019337:Hematologic Neoplasms / Q000150:complications* / Q000188:drug therapy; D006509:Hepatitis B / Q000209:etiology* / Q000503:physiopathology; D006801:Humans; D016393:Lymphoma, B-Cell / Q000150:complications* / Q000188:drug therapy; D008297:Male; D000069283:Rituximab
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab